Wu Hongwei
Title: Associate Chief Physician, Doctor of Medicine, Doctoral Supervisor
Ph.D. in Surgery from Xiangya School of Medicine, Central South University; Research Fellow in the “Top 100 Clinical Scholars” program at Zhejiang University School of Medicine; Ph.D. and postdoctoral advisor; trained under Professor Ouyang Hongwei, a renowned expert in joint and sports medicine at Zhejiang University. He spent over two years conducting advanced training at Yale University in the United States and the University Hospital of Saarland in Germany. With nearly 20 years of experience in the clinical practice and research of orthopedic diseases, his primary focus is on bone and joint injuries and rapid regenerative therapies. He has developed large-scale transplantable stem cell organoids that significantly promote tissue regeneration; a novel bioactive hydrogel that markedly improves healing outcomes in mosaic bone-cartilage defect grafting; and standardized tumor organoid animal models that greatly facilitate the evaluation of clinical treatment efficacy for tumors. Clinically, he specializes in hip and knee joint replacement and revision surgeries, as well as the surgical treatment of bone tumors and bone metastases. He is particularly skilled in minimally invasive arthroscopic-assisted treatments for conditions such as frozen shoulder, rotator cuff injuries, meniscal tears, cruciate ligament injuries, and cartilage damage in the knee and ankle joints. He consistently upholds a patient-centered approach with a focus on humanistic care and standardized disease treatment, and is dedicated to applying cutting-edge research technologies to clinical practice to maximize patient benefits. He has won multiple awards in national and provincial medical innovation and entrepreneurship competitions.